S2Medical AB Announced Positive outcome from evaluation of Epiprotect in Saudi Arabia. The Natnal UnUnified Procurement Company (NUPCO) in Saudi Arabia has completed its evaluation of Epiproct at 5 major r hospitals. The evaluation, which is part of the process of procuring Epiprotect in the country, gave a very positive outcome and is now reported to NUPCO, which is expected to provide a purchase code for the product.

The purchase code that is expected to be registered within 2 months will allow orders through the national purchasing unit that supplies most of the Saudi healthcare market consisting of over 500 hospitals with medical supplies. The 5 hospitals that participated in the evaluation estimate their initial needs to about 1500 pcs of Epiprotect per month, which corresponds to about SEK 12.6 million per year. This consumption mainly relates to the treatment of superficial burns and is expected to increase gradually as more and more hospitals will start to use the product.

The healthcare facilities that evaluated Epiprotect are very positive about the product and have expressed their intention to start purchases as soon as the purchase code is generated.